Ronald M. Krauss

发表

ATHENA: A Tool for Meta-Dimensional Analysis Applied to Genotypes and Gene Expression Data to Predict HDL Cholesterol Levels

Marylyn D. Ritchie, Scott M. Dudek, Marisa Wong Medina, 2012, Pacific Symposium on Biocomputing.

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Lale Tokgözoğlu, Ian Graham, Stephen J. Nicholls, 2017, European heart journal.

Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin

Feng Gao, Marisa Wong Medina, Jerome I. Rotter, 2008, Circulation.

LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

George Hripcsak, Joshua C. Denny, Peggy L. Peissig, 2018, Circulation.

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin

Ronald M. Krauss, Lara M. Mangravite, Elizabeth Theusch, 2012, PLoS genetics.

Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome

Rob Knight, Jörg Bernhardt, Jason E. McDermott, 2017, mBio.

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

Russell A. Wilke, Dan M. Roden, Issam Zineh, 2008, Nature Reviews Drug Discovery.

Discovery and Refinement Supplementary

Christian Gieger, Cisca Wijmenga, Inês Barroso, 2015 .

American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease

Ronald M. Krauss, R. Krauss, R. Eckel, 1998 .

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

Paul T. Williams, Russell A. Wilke, Matthew Stephens, 2010, PloS one.

CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake

Russell A. Wilke, Qiping Feng, Ronald M. Krauss, 2012, PloS one.

Validation of Electronic Health Records for the Assessment of Statin Dosing In Research

Carlos Iribarren, Ronald M. Krauss, Akinyemi Oni-Orisan, 2017 .

Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment

Peter D. Karp, Oliver Fiehn, Rima Kaddurah-Daouk, 2012, PloS one.

The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change

Tanushree Haldar, Carlos Iribarren, Ronald M. Krauss, 2020, npj Genomic Medicine.

Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment

Rima Kaddurah-Daouk, Zhao-Bang Zeng, Ronald M. Krauss, 2011, PloS one.

Low-density lipoprotein subclasses and risk of coronary artery disease

Ronald M. Krauss, R. Krauss, 1991 .

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

Matti Pirinen, David M. Herrington, Alex Doney, 2014, Nature Communications.

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

Olle Melander, Eric E. Schadt, Sekar Kathiresan, 2010, Nature.

A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK

Ronald M. Krauss, Melissa A. Austin, M. King, 1990 .

A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women[S]

Olle Melander, Peter Almgren, Marju Orho-Melander, 2010, Journal of Lipid Research.

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

Russell A. Wilke, Dan M. Roden, Issam Zineh, 2007, Nature Reviews Drug Discovery.

The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals

Xiaofeng Zhu, Vladan Mijatovic, Inês Barroso, 2016, Nature Genetics.

Association of the APOLIPOPROTEIN A 1 / C 3 / A 4 / A 5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia

Päivi Pajukanta, Janet S. Sinsheimer, Aldons J. Lusis, 2004 .

Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake

Feng Gao, Marisa Wong Medina, Ryan E. Temel, 2011, PloS one.

Major clinical trials of hypertension: what should be done next?

Thomas D. Giles, Eric Boerwinkle, John B. Kostis, 2005, Hypertension.